ESSENTIAL HYPERTENSION
Clinical trials for ESSENTIAL HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new ESSENTIAL HYPERTENSION trials appear
Sign up with your email to follow new studies for ESSENTIAL HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood pressure breakthrough? new study tests Drug-Free remission
Disease control Not yet recruitingThis study tests whether a 12-week intensive lifestyle program (diet, exercise, sleep, stress management) combined with a careful plan to reduce blood pressure medication can help people with high blood pressure achieve remission. The goal is to see if participants can safely sto…
Matched conditions: ESSENTIAL HYPERTENSION
Phase: NA • Sponsor: Evelyn Vanina Re • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Zapping the brain to lower blood pressure? new trial explores a needle-free approach.
Disease control Not yet recruitingThis study tests whether a gentle, non-invasive brain stimulation technique (called temporal interference stimulation) can safely lower blood pressure in people with mild hypertension. About 60 adults aged 30–65 with untreated mild high blood pressure will receive either real or …
Matched conditions: ESSENTIAL HYPERTENSION
Phase: NA • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New hypertension drug shows promise in Mid-Stage trial
Disease control Not yet recruitingThis study tests five different doses of a new medicine called BR1400 in 330 adults with high blood pressure (essential hypertension). The goal is to see how well each dose lowers blood pressure and if it is safe. Participants will take the medicine for 8 weeks, and their blood p…
Matched conditions: ESSENTIAL HYPERTENSION
Phase: PHASE2 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New blood pressure combo tested in healthy volunteers
Knowledge-focused Not yet recruitingThis early-stage study tests a new combination of drugs for high blood pressure in 48 healthy adults. Researchers want to see how the drugs are absorbed and if they are safe when taken with food. The study does not offer treatment but helps gather important information for future…
Matched conditions: ESSENTIAL HYPERTENSION
Phase: PHASE1 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated May 17, 2026 07:59 UTC
-
New blood pressure combo tested in healthy volunteers
Knowledge-focused Not yet recruitingThis early-stage trial will test a new drug combination for high blood pressure in 48 healthy adults. Participants will take the drugs by mouth after eating, and researchers will measure how the drugs move through the body and check for side effects. The goal is to gather safety …
Matched conditions: ESSENTIAL HYPERTENSION
Phase: PHASE1 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC
-
New blood pressure combo drug tested in healthy volunteers
Knowledge-focused Not yet recruitingThis early-stage study will test a new combination of two blood pressure medicines (BR1015-1 and BR1015-2) in 58 healthy adults. The goal is to see how the drugs move through the body and if they are safe when taken together. Participants will take single doses under fasting cond…
Matched conditions: ESSENTIAL HYPERTENSION
Phase: PHASE1 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated May 11, 2026 20:49 UTC
-
Healthy volunteers test new combo pill for high blood pressure
Knowledge-focused Not yet recruitingThis early-stage study tests a new combination drug (BR1015-A) for high blood pressure in 58 healthy adults. Researchers will measure how the drug moves through the body and check for side effects. The goal is to gather safety and dosing information before testing in patients wit…
Matched conditions: ESSENTIAL HYPERTENSION
Phase: PHASE1 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC